Pilot Trial for Treatment of Recurrent Glioblastoma

Clinical trial NCT05432518 · RECRUITING

Trial details

NCT number: NCT05432518
Sponsor: AHS Cancer Control Alberta
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Recurrent Disease Recurrent Glioblastoma

Start date: 2023-06-27
Primary completion: 2027-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.